HCAT
Health Catalyst Inc

812
Mkt Cap
$152.78M
Volume
1.06M
52W High
$5.68
52W Low
$2.02
PE Ratio
-1.37
HCAT Fundamentals
Price
$2.06
Prev Close
$2.16
Open
$2.17
50D MA
$2.41
Beta
1.63
Avg. Volume
579,810.35
EPS (Annual)
-$1.15
P/B
0.46
Rev/Employee
$204,389.33
$435.77
Loading...
Loading...
News
all
press releases
Here's Why Health Catalyst (HCAT) Is a Great 'Buy the Bottom' Stock Now
Health Catalyst (HCAT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks·13d ago
News Placeholder
More News
News Placeholder
4 Analysts Have This To Say About Health Catalyst
read more...
Benzinga·1mo ago
News Placeholder
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Brokerages
Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been assigned a consensus rating of "Hold" from the fourteen research firms that are currently covering the company, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) General Counsel Benjamin Landry sold 27,425 shares of Health Catalyst stock in a transaction on Friday, December 5th. The shares were sold at an...
MarketBeat·2mo ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) Director Julie Larson-Green sold 47,997 shares of Health Catalyst stock in a transaction dated Thursday, December 4th. The stock was sold at an...
MarketBeat·2mo ago
News Placeholder
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has been assigned an average recommendation of "Hold" from the fourteen brokerages that are currently covering the firm, Marketbeat Ratings...
MarketBeat·2mo ago
News Placeholder
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder...
PR Newswire·2mo ago
News Placeholder
Health Catalyst, Inc. $HCAT Shares Acquired by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. boosted its position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 53.6% in the second quarter, according to its most recent disclosure with...
MarketBeat·3mo ago
News Placeholder
Health Catalyst (NASDAQ:HCAT) Price Target Lowered to $3.25 at Citigroup
Citigroup cut their price target on shares of Health Catalyst from $3.50 to $3.25 and set a "neutral" rating on the stock in a report on Tuesday...
MarketBeat·3mo ago
News Placeholder
Stifel Nicolaus Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price
Stifel Nicolaus dropped their price target on Health Catalyst from $4.50 to $3.75 and set a "hold" rating for the company in a research note on Tuesday...
MarketBeat·3mo ago
<
1
2
...
>

Latest HCAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.